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Abstract 
Inflammation of the middle ear (otitis media) comprises a group of disorders that are 
highly prevalent in childhood, and indeed are amongst the most common disorders of 
childhood. Otitis media is also heritable, and has effects on fecundity. This means that 
otitis media is subject to evolution, yet the evolutionary selection forces that may 
determine susceptibility to otitis media have never been adequately explored. 
 Here I undertake a critical analysis of evolutionary forces that may determine 
susceptibility to middle ear inflammation. These forces include those determining 
function of the middle ear, those affecting host immunity, and those affecting 
colonization by, and pathogenicity of bacteria. I review existing mathematical 
evolutionary models of host-pathogen interaction and co-evolution, and apply these to 
develop a better understanding of the complex evolutionary landscape of middle ear 
infection and inflammation in humans. This includes an understanding of factors 
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determining the transition between stable evolutionary strategies for host and bacterial 
pathogens. This understanding will be later applied to analysis of otitis media in 
indigenous populations. 
 In the second part of this article, I apply the approach of population genetics to 
devise a new theory for the high prevalence of otitis media in certain indigenous 
populations: the Australian Aborigine, the Native American, the Inuit, and the Maori. 
I suggest that high prevalence in such groups may have occurred as a result of 
colonization of these previously isolated populations by European immigrants in the 
15th and 16th Centuries. This exposed them to new strains of bacteria to which their 
immune system had not evolved immunity, perturbing a previously stable host-
pathogen co-evolutionary state. 
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Inflammation of the middle ear is termed otitis media (OM), and is a very common 
affliction of childhood. OM has several phenotypes, which are inter-related (Bhutta 
2014). Infection of the middle ear, is termed acute otitis media (AOM), and is the 
most common bacterial infection in childhood, afflicting 59% of two year old children 
in a developed world environment (Teele et al 1989). Other children develop 
persistent effusion (fluid) in the middle ear, which when lasting at least three months 
is termed chronic otitis media with effusion (COME). COME affects 5–6% of two-
year old children in the developed world, and is the most common cause of hearing 
loss in children. In the developing world, many children and adults suffer from 
persistent infection of the ear, manifesting as purulent discharge from the ear. This is 
termed chronic suppurative otitis media (CSOM), and is estimated to affect 200 
million people worldwide (Monasta et al 2012), with significant hearing loss in 160 
million of these (Murray CJL 1996). 
 Otitis media is also highly heritable. Heritability of recurrent ear infections 
(recurrent acute otitis media, rAOM) in white infants has been estimated to be 0.49 
(Rovers et al 2002). In chronic otitis media with effusion (COME), time with effusion 
has heritability of 0.73 (Casselbrant et al 1999). For chronic suppurative otitis media 
(CSOM) a study in the Inuit population reported a 2.55 odds ratio of disease in those 
with parental history (Jensen et al 2011). 
 Otitis media can also affect reproductive fitness. Current global deaths from 
OM (largely due to intracranial spread of infection from AOM) are estimated at 
21,000 annually, and these by and large occur in early childhood (Monasta et al 
2012), before reproduction has occurred. This is in the context of 709 million global 
cases of AOM annually (Monasta et al 2012), meaning that the calculated case fatality 
rate is only 0.0003%. Importantly, this is much lower than case fatality rates for other 
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respiratory infectious diseases: for example severe paediatric pneumonia in resource-
limited settings can carry a case mortality rate as high as 10% (Enarson et al 2014). 
Chronic otitis media can also affect reproductive fitness, through effects on hearing 
due to erosion of the ossicles (middle ear bones), or by filling the middle ear with 
effusion. The effect of the hearing loss on reproductive fitness is difficult to quantify.  
 Hence, otitis media comprises a set of disorders that are common, that are 
highly heritable, and that can affect reproductive fitness. This set of circumstances 
means that susceptibility to OM will be subject to evolutionary forces. At face value, 
this set of circumstances may actually suggest that susceptibility to otitis media 
should undergo negative selection, and so become rare. This is not the case. Erosion 
of the temporal bone has been documented in a 40,000 year old human skull (Day 
1977, Montgomery 1994), implying that morbidity and mortality from OM has 
featured throughout the evolutionary history of modern humans, and it is certainly 
still highly prevalent today. 
 Otitis media remains prevalent because it is a complex infectious disease. 
Bacteria that normally reside in the human nasopharynx are the cause of AOM, when 
they ascend up the Eustachian tube into the middle ear (figure 1). Chronic forms of 
OM are probably also a consequence of bacterial infection (Bhutta 2014). The 
evolutionary forces that drive human susceptibility to middle ear inflammation cannot 
therefore be considered in isolation, but rather exist in complex interplay with the 
evolutionary forces affecting colonization, survival and pathogenicity of bacteria 
living in the nasopharynx. The evolutionary battle between host and pathogen is a 
perpetual phenomenon (Karlsson et al 2014), and the continued contemporary 
prevalence of otitis media is testament to this fact.  
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 In this essay I will undertake a novel analysis of the evolutionary forces at 
play in otitis media, and try to unpick some of the underlying complexity.Bluestone 
has suggested that human susceptibility to otitis media is closely related to evolution 
of craniofacial morphology (Daniel 1999), and in particular the angulation and calibre 
of the Eustachian tube (Bluestone 2008, Bluestone & Swarts 2010). These ideas are 
premised on the notion that anatomy or function of the Eustachian tube is the major 
determinant of susceptibility to OM (Bluestone 2005), but this premise is 
questionable, and seems insensitive to the complexities of host and pathogen 
interaction. There is little evidence that the Eustachian tube is in some way abnormal 
in the OM susceptible population: in fact most evidence suggests no difference (de Ru 
& Grote 2004, Sade & Ar 1997). Bluestone also suggests that otitis media is almost 
unique to humans (Bluestone & Swarts 2010), but actually OM is well documented by 
the veterinary community in small and large domestic animals, including dogs, cats, 
rabbits, ruminants, horses, pigs, and camelid, although it can be difficult to diagnose 
(Kahn & Line 2010). It seems likely that otitis media is also prevalent in non-
domesticated animals. 
 The factors at play in the evolution and genetics of human otitis media will not 
be simple. They will incorporate selection pressures determining function and 
dysfunction of the middle ear and the host immune system, together with models of 
population genetics and host-pathogen interaction and co-evolution. Here I will 
consider these factors in turn, to build a better understanding of evolution as it 
pertains to middle ear inflammation. I will then integrate this analysis into a new 
theoretical model to understand why certain indigenous populations have a high 
propensity to otitis media, underlining the importance of how an understanding of 
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evolutionary forces can be used to understand factors determining contemporary 
human disease. 
 
Evolutionary forces affecting function of the middle ear, nasopharyngeal 
microbiome, and host immunity 
Evolution of the middle ear 
When animals transitioned from an aquatic to a terrestrial existence this created a 
significant mismatch in sound impedance from the interface between the air-filled 
environment and the fluid filled inner ear. The middle ear evolved as an air-filled 
sound transformer to overcome this mismatch. In humans the middle ear provides up 
to a 27 decibel gain in hearing for air-borne sound (Kurokawa & Goode 1995). 
Between the Carboniferous and Triassic periods the middle ear independently evolved 
in five lineages—the anurans, turtles, lepidosaurs, archosaurs and mammals 
(Christensen-Dalsgaard & Carr 2008), and such convergent evolution is evidence of 
the survival advantage of an air-filled space to hearing in a terrestrial environment. 
 Thus, the primary function of the middle ear is to provide and maintain a gas 
pocket at atmospheric pressure, and even relatively minor alterations to the gaseous 
composition can affect hearing (Haggard 2009, Lildholdt et al 1979, Margolis et al 
1994, Petrova et al 2006). Exchange of oxygen, carbon dioxide, and nitrogen between 
the middle ear space and venous blood occurs across the lining of the postero-superior 
middle ear cleft (Ars et al 1997), assisted by intermittent opening of the Eustachian 
tube (Adil & Poe 2014) (figure 1). Many mammals have a posterior extension of the 
middle ear known as the bulla, but in humans this is extensive and forms a series of 
interconnected air cells into the mastoid process of the temporal bone. The mastoid 
process probably evolved to redirect the pull of the sternocleidomastoid muscle on the 
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skull, to compensate for hominid adoption of an upright stance (Krantz 1963), but 
how and why this subsequently became pneumatised is not known. It may be that 
such pneumatisation increases area for gas exchange (Takahashi 2001), but why this 
should be necessary or advantageous in hominids is not clear. 
 To maintain a surface for gaseous exchange (Ar et al 2007) the middle ear is 
kept free of pathogens (Westerberg et al 2008) and particulate matter (and in this 
regard resembles the lung). Hence the antero-inferior region of the middle ear 
(including the Eustachian tube) is tasked with host defence (Ars & Ars-Piret 1997) 
and is lined with a lining that secretes and propels mucus to defend against bacterial 
ingress (Lim et al 2000). The normal middle ear has a paucity of white cells (Lim et al 
2000) suggesting that mucus clearance alone is usually effective, despite the infant 
middle ear being positioned only 2cm (Ishijima et al 2000) from bacteria living in the 
nasopharynx. 
 
Evolution of nasopharyngeal bacteria 
Colonisation of the nasopharynx is the source of bacteria that cause AOM (Hotomi et 
al 2004, Tonnaer et al 2005), and therefore the initiating site for almost all OM 
phenotypes. Colonisation occurs rapidly after birth, and the nasopharyngeal bacterial 
flora is established in the first year of life (Garcia-Rodriguez & Fresnadillo Martinez 
2002). By infancy the nasopharyngeal microbiome is complex and formed of an 
average of six million bacteria (Wilson 2005) and 20–87 different species 
encompassing 13 taxonomic phyla. The most common genera (figure 2) are 
Moraxella, Haemophilus, Streptococcus, and Flavobacterium (Bogaert et al 2011). 
The flora are dynamic and individualized (Bogaert et al 2011): bacterial species may 
be acquired, lost and re-acquired (Faden et al 1995), including through inter-species 
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competition (Bogaert et al 2004, Murphy et al 2009), or subject to seasonal variations 
(Bogaert et al 2011). 
 Nasopharyngeal commensal bacteria are ecotropic, site-specific, and have co-
evolved with their host. The majority of commensals exist in a symbiotic, or at least 
tolerated relationship: they rarely cause disease, may prevent colonization with 
potential bacterial pathogens, and can reside in the nasopharynx of their host 
throughout life. In contrast some species, notably Streptococcus pneumoniae, non-
typeable Haemophilus influenza (NTHi), or Moraxella catarrhalis, do have 
pathogenic potential. Exposure to new strains of these bacteria can result in clearance, 
asymptomatic colonization (Faden et al 1991, Prellner et al 1984a), or respiratory tract 
infection, including AOM (Faden et al 1997, Gray et al 1980), but also rhinosinusitis 
(Brook & Gober 2007) or pneumonia (Hausdorff & Dagan 2008). Such disease 
usually occurs following viral URTI (Bhutta 2014), suggesting virulent bacteria and 
upper respiratory tract viruses have likely co-evolved. Mechanisms of viral-bacterial 
co-evolution have not been explored. No particular virus appears to synergise with 
any bacterial strain (Alper et al 2009), and there appears to be convergent evolution, 
in that viruses use species-specific mechanisms for synergistic bacterial infection 
(Avadhanula et al 2006), which may include promotion of bacterial adhesion, 
disruption of the epithelial barrier, and interference with the host immune system 
(Bosch et al 2013). Perhaps synergism allows viral and bacterial species to together 
seize an opportunity to overwhelm the host immune system and so expand their 
populations. Synergism could also be to capitalise on symptoms such as cough, which 
can be invoked by viruses (Footitt & Johnston 2009) and possibly also bacteria 
(Gunnarsson et al 2000), or sneezing, which generate bioaerosols and so enhance 
pathogen spread (Fiegel et al 2006).  
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 Bacteria that colonise the human nasopharynx seem to have adopted strategies 
of either virulence or avirulence, and mathematical models (Boots et al 2009, Miller 
et al 2005) predict these two outcomes to be co-evolutionary stable states. Avirulence 
will likely lead to host tolerance and long-term carriage, thus favouring microbe 
spread between hosts over prolonged periods. Virulence enables massive bacterial 
population expansion during the pathogenic phase, thus promoting spread between 
susceptible hosts (which in the case of AOM will largely be infants that naturally are 
relatively immunodeficient), but with the disadvantage that colonization may be only 
short-term if (when) the host generates an immune response sufficient for eradication. 
The major otopathogens S. pneumoniae, NTHi, or M. catarrhalis can often be 
cultured from the nasopharynx of infants, but are rarely found in adults (Garcia-
Rodriguez & Fresnadillo Martinez 2002, Gunnarsson et al 1998), and I suggest this is 
because immune response in the host leads to their eventual clearance, although 
formation of a bacterial biofilm (Murphy et al 2009) may afford some protection. 
 Advances in genetic sequencing have provided further insight into the 
transition between evolutionary strategies for the nasopharyngeal microbiome. For 
example M. cattarhalis probably attained virulence coincident with, and as a 
consequence of, human population expansion (Wirth et al 2007), although the 
molecular mechanisms are unclear (Davie et al 2011). Sequencing data suggests that 
Streptococcus pneumoniae evolved as a derivative of the commensal species 
Streptococcus mitis, through horizontal gene transfer that enabled a diverse structure 
to its cellular wall, creating bacterial virulence (Kilian et al 2008, Kilian et al 2014). 
The evolutionary history of Haemophilus influenzae is not well understood (Maughan 
& Redfield 2009). Of course, these strategies are not mutually exclusive. Not all 
colonization with S. pneumoniae, NTHi, or M. cattarhalis leads to disease, and 
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commensals like Fusobacterium necrophorum or group A streptococci that are 
normally avirulent can occasionally be pathogenic and cause otitis media (Le Monnier 
et al 2008, Turner et al 2002). Indeed the evolutionary dynamics will be affected by 
many factors, including pathogen transmission rates and risk of mortality (Hoyle et al 
2008) but also, and importantly, host population ecology (Frank 1991). In particular, 
existing computer modeling suggests that expanding host populations favour 
pathogen virulence, whereas stable or declining populations favour avirulence.  
 
Evolution of host immune response 
The ontogeny and phylogeny of the immune system is from mucosal epithelium 
(Drayton et al 2006), reflecting that this is the entry point for most infectious agents 
(Murphy et al 2008). The mucosa associated lymphatic tissue (MALT) contains 80% 
of all immunocytes, is separate in structure and function from the systemic immune 
system, and is compartmentalised into gut-associated lymphatic tissue (GALT) and 
nasal associated lymphatic tissue (NALT) (Holmgren & Czerkinsky 2005).  
 Infectious disease is a major driver of evolution (Karlsson et al 2014), and 
given the morbidity and mortality of respiratory infections (Schluger 2010), function 
of NALT will have been, and continue to be, subject to major evolutionary pressure. 
However, mucosal immune regulation remains poorly understood, and in particular 
the mechanisms that determine tolerance versus an active immune response—
although secretory immunoglobulin A appears to play an important role (Strugnell & 
Wijburg 2010). 
 NALT in humans is particularly well developed in comparison to other 
mammals such as rodents, and is arranged as lymphoid aggregates that form a ring 
(Waldeyer’s ring) at the inlet to the pharynx/throat (figure 3) (Brandtzaeg 2003). This 
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development perhaps reflects the fact that humans are a societal species, with high 
exposure to air-borne microorganisms through social contact. Importantly, NALT is 
embryologically and functionally distinct from GALT (Kiyono & Fukuyama 2004, 
Ruddle & Akirav 2009), evidencing that it has been subject to site-specific 
evolutionary forces (Wu & Russell 1997). Empirically, this suggests that upstream 
regulators of the immune response in NALT have also evolved to be site-specific, 
although downstream (phylogenetically ancient) signaling may utilise pathways in 
common with the rest of the immune system. Evidence from other contexts reveals 
wide variation in immune function in different tissue types (Matzinger & Kamala 
2011). The components of different tissues that determine this variation in immune 
function are not well understood, but seem important. 
 A priori it may appear that the host population should be constantly striving to 
win the arms race against potentially pathogenic microorganisms, but this is not 
necessarily true. The immune system consumes significant energy capital 
(Muehlenbein et al 2010), and so the usage costs (and risks of morbidity and 
mortality) of fighting an infection are balanced by the resource investment required to 
maintain an immune system (Sheldon & Verhulst 1996). In addition, because 
pathogens usually have a shorter generation time and larger population size than their 
hosts, they are more adaptable, and so the host may never completely win this battle 
(Schulenburg et al 2009). Population models suggest that for species such as humans, 
that are long-lived and utilise acquired immunity, the optimum evolutionary strategy 
may be to allow the occasional infection (Schmid-Hempel 2003). If the host survives 
the infection, acquired immunity will prevent similar infection in the future, but the 
pre-programmed lower basal investment in immune maintenance may increase 
fecundity over the lifetime of the individual. The optimum strategy will vary with host 
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and population dynamics, thus engendering intra-species diversification, and 
genotypic variation with regard to host immune response (Miller et al 2007).  
 Prolonged (chronic) inflammatory response may occur as a result of persistent 
antigenic stimulation, but may also be pre-programmed, for example as a strategy to 
enhance clearance of antigens (Caruso et al 2004). There is evidence that human 
evolution has favoured a more pro-inflammatory genotype when compared to other 
primates, perhaps to enhance pathogen clearance, and thus engender longevity of our 
species (Finch 2010) and the unique system of multigenerational support in child 
nurture that this affords (Hawkes 2004). However, chronic inflammation can be 
maladaptive (Medzhitov 2008), and risks causing irreparable tissue damage (Karin et 
al 2006). Pro-inflammatory genotypes exemplify antagonistic pleoitropy (Leroi et al 
2005), whereby a polymorphism may serve a useful function in the short term but 
have negative consequences in the longer term.  
 
The Genetic Landscape of Otitis Media 
We can apply some of the broad principles of population genetics to understand the 
genetic landscape of otitis media. 
 
Susceptibility to rAOM 
Importantly, the phenome of susceptibility to rAOM includes susceptibility to other 
respiratory tract infections, including tonsillitis (Kvaerner et al 1996, Kvestad et al 
2006), rhinosinusitis (Kvaerner et al 1996), and bronchopulmonary infections 
(Stenstrom & Ingvarsson 1994), and, to a lesser extent, susceptibility to extra-
respiratory mucosal infections (Stenstrom & Ingvarsson 1994). The association with 
bronchopulmonary infections occurs because AOM and most lower respiratory tract 
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infections (LRTI) are alternate (or common) outcomes of nasopharyngeal 
colonization by the same species of respiratory pathogens. Because mortality due to 
LRTI (Schluger 2010) is more prevalent than that due to intracranial spread of middle 
ear infection (Monasta et al 2012, WHO 2004), prevention of LRTI will likely be the 
main determinant of host investment in NALT immune function. The lower 
respiratory tract is also likely to be the preferred site for infection by pathogenic 
bacteria; LRTI aids bioaerosol dispersion, but there is relatively little to be gained for 
the pathogen through infection of the middle ear space. Thus, the middle ear may be 
an unfortunate bystander in the battle of host versus respiratory pathogen. The middle 
ear is susceptible to infection, yet exerts comparatively little evolutionary pressure to 
prevent such infection. 
 The high heritability of rAOM implies that host response is the main 
determinant of disease susceptibility, specifically NALT immune response to 
potentially virulent infectious agents (Faden 2001, Garcia-Rodriguez & Fresnadillo 
Martinez 2002, Rynnel-Dagoo & Agren 2000). Some evidence supports this notion. 
First the pathogens causing rAOM are the same as those causing AOM (Pichichero 
2000), but children prone to rAOM experience nasopharyngeal bacterial colonisation 
more frequently (Faden et al 1991, Harabuchi et al 1994) and with higher density 
(Stenfors & Raisanen 1992), although this may also be found in children with COME 
(Marchisio et al 2003)). Quantitative or qualitative defects in plasma 
immunoglobulins have been found in some, but not all, of those with rAOM (Freijd et 
al 1984, Freijd et al 1985, Harsten et al 1989, Hotomi et al 1999, Prellner et al 1984b, 
Stenfors & Raisanen 1993, Yamanaka & Faden 1993). 
 Extrapolation from other infectious diseases suggests that susceptibility to 
rAOM will likely factor a very large number of genes (Burgner et al 2006). The arms 
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race between pathogen and host has engendered a complex immunological network of 
pathogen recognition and signaling molecules in the host, and with considerable 
redundancy (Nish & Medzhitov 2011). Susceptibility loci may encompass those 
determining bacterial adhesion, mucociliary clearance, innate immune response, or 
adaptive immune response, and may be those regulating such functions throughout the 
mucosa, or more specifically only in nasopharyngeal mucosa. We still know relatively 
little about human genetic susceptibility to rAOM (Rye et al 2012). 
 
Susceptibility to COME 
For chronic otitis media, we may hypothesise from evolutionary theory (Medzhitov 
2008) that because persistent middle ear inflammation is common it must have at least 
some beneficial effect (Cochran et al 2000). Empirically, this inflammation could aim 
to enhance clearance of, or prevent proliferation of, microorganisms (de Ru & Grote 
2004), and there is evidence to support this idea. Bacterial mRNA can be detected in 
37–94% of effusions in COME (Calhoun et al 1988, Giebink et al 1982, Gok et al 
2001, Hendolin et al 1997, Liu et al 1976, Liu et al 1975, Palva et al 1983, Park et al 
2004), suggesting that metabolically active bacteria are present, but are constrained in 
their proliferation. Indeed, the effusion in OME has been shown to be bacteriostatic 
(Siirala 1952) and bactericidal (Shimizu et al 1988), presumably due to the mucins, 
immunoglobulins, and cytokines within the effusion. The viability of bacteria in 
effusions negatively correlates to the levels of such constituents (Lang et al 1976, Lim 
et al 1979, Liu et al 1976). There is a (small) increase in AOM following insertion of 
ventilation tubes for COME (which removes the effusion), which further evidences 
potential anti-bacterial effects of the effusion (Ingels et al 2005) (although very few 
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studies of ventilation tubes have specifically looked at this outcome (Browning et al 
2010, Rosenfeld 2000)).  
 The reverse hypothesis has also been advanced, that the effusion in OME 
provides the milieu for increased bacterial colonization, and so contributes to AOM. It 
is true that AOM can be immediately preceded by OME, but this may reflect the 
imperfection of a sero-mucoid effusion in its attempt to prevent suppuration, rather 
than implying that it contributes to that suppuration. With rAOM, the common 
observation that OME is also present may represent recurrent rather than chronic 
OME. 
 Whereas protection against microorganisms may possibly be the advantage, 
and possibly the evolutionary purpose of chronic otitis media, clearly prolonged 
inflammation can also be detrimental. Prolonged effusion in COME creates an air-
fluid interface that prevents the transmission of sound, and thus counteracts the 
purpose of the middle ear. The consequential hearing loss could reduce audition of 
danger but the handicap will be somewhat ameliorated, at least during infancy, by the 
long parent-child bond in our species. Reduced hearing can also interfere with 
language acquisition, although the long-term consequences of COME on linguistic 
abilities are debated (Roberts et al 2004). Consequently chronic inflammation of the 
ear in infancy may have relatively little effect on fecundity, and there may be little 
evolutionary pressure to select against it. In the longer-term middle ear fibrosis, 
tympanic retraction, chronic otorrhoea, or erosion of the bones of hearing can lead to 
irreversible hearing loss, but these consequences are relatively rare and may be offset 
by any potential advantage of chronic inflammation in earlier life. 
 Pathways driving chronicity of inflammation are not well understood. It is not 
known to what extent chronic inflammation results from a failure of catabolism of 
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pro-inflammatory mediators, and to what extent it may be a failure of induction of 
pro-resolution programs (Serhan et al 2007). Nor do we know the relative roles of 
leucocytes, stromal cells or mucosal cells in this process. Whereas the acute 
inflammatory response invokes a very large number of pathways, and with 
redundancy, empirically it is plausible that a smaller number of pathways are involved 
in driving chronicity of inflammation. Indeed homozygous polymorphisms in acute 
inflammatory response genes rarely cause a significant phenotype, whereas similar 
polymorphisms in key regulators of inflammation can lead to chronic inflammation 
(Wells et al 2005).  
 Chronic OM is not knowingly associated with chronic inflammation in extra-
tympanic sites, in childhood nor in later life (but this question has never been 
adequately investigated). Given the development of site-specificity of immune 
response in latter phlylogeny, and the lack of evidence of extra-tympanic 
inflammation, it may be that susceptibility to chronic middle ear inflammation is 
determined by only a handful of genes that function as locoregional regulators of 
inflammation.  
 
Ethnic variations in otitis media incidence 
The earlier analysis and understanding of the complex forces at play in otitis media 
susceptibility can be used to understand why certain populations are more susceptible 
to otitis media. 
 A number of studies have reported differences in prevalence of otitis media by 
ethnicity. These differences could be due to ethnic variations in socio-economic 
factors (Vernacchio et al 2004) or in illness-seeking behavior (Park et al 2002), as 
well as genetics, but because many studies have been retrospective they have been 
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unable to control for such confounders. Furthermore studies have been contradictory, 
and the conclusions of systematic (Smith & Boss 2010) and narrative (Bluestone 
2005, Bluestone & Klein 2007, Casselbrant 2003) reviews do not agree on differences 
in OM prevalence between white, black, Hispanic or Asian children in the developed 
world. In the developing world only CSOM has been studied in any detail, but 
methodological differences and inconsistent disease definition make it difficult to 
compare reported geographical variations in prevalence (Monasta et al 2012, WHO 
2004). 
 However, there are reliable data that show a high prevalence of otitis media in 
children of the indigenous Inuit (Curns et al 2002, Ling et al 1969, Maynard et al 
1972, Pedersen & Zachau-Christiansen 1986, Reed et al 1967, Singleton et al 2009), 
Native American (Curns et al 2002, Maynard et al 1972, Singleton et al 2009, Zonis 
1968), Maori (Giles & Asher 1991, Gribben et al 2012, Hamilton et al 1980, Stanhope 
et al 1978), or Australian Aborigine (Boswell & Nienhuys 1995, Gunasekera et al 
2007, Morris et al 2005, Williams et al 2009) populations when compared to white 
conspecifics. These indigenous groups seem more susceptible to both AOM and 
CSOM (table). Socioeconomic disparities may contribute to this difference, but the 
incidence of OM in indigenous groups is exceptionally high, suggesting that genetic 
differences are likely to be important.  
 It has been mooted that anatomical factors in Eustachian tube morphology or 
in middle ear anatomy may underlie ethnic variation in OM incidence, but data to 
support this theory are weak (Beery et al 1980, Bluestone 2005, Jassar et al 2006, 
Wiet et al 1982). Craniofacial differences in human populations appear to have arisen 
largely as a consequence of genetic drift (Betti et al 2010), rather than evolutionary 
pressures. Because of the current lack of good evidence that a particular craniofacial 
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form is responsible for ethnic variations in OM susceptibility, theories based on this 
premise seem weak. They also seem undermined by the fact that these ethnic groups 
listed above are not particularly closely related. Thus, I feel alternative explanations 
should be considered. 
 Here, I present an alternative hypothesis, based upon population genetics and 
phylogeography. Prior to European exploration and colonization in the late 15th and 
16th Centuries (figure 4), the Eurasian and African populations numbered in the 
hundreds of millions, and were sympatric (they probably interbred until 20–40,000 
years ago, (Li & Durbin 2011). Thus, it seems likely that microorganisms would have 
spread across the African and Eurasian populations, aided by regional and inter-
continental trade, and (for respiratory microorganisms) by wind. In comparison, the 
Inuit, Native American, Maori, and Australian Aboriginal populations at this time had 
relatively small total and demic population sizes, and each of these populations lived 
in relative geographic and social isolation. Hence, for the large part they were 
exposed only to local or regional microorganisms. In addition, indigenous populations 
had experienced repeated population bottlenecks (Manica et al 2007), which had 
reduced the genetic diversity in these isolated groups (Mulligan et al 2004) compared 
to Eurasian or African conspecifics (DeGiorgio et al 2009). The effect of these 
bottlenecks on associated microbial diversity is not well known. 
 Given that the Inuit, Native American, Maori or Australian Aborigine 
populations were largely separated from Eurasian and African populations for a 
period of 30–45,000 years, we would expect these groups to have diverged through 
genetic drift. Similarly we would expect drift to lead to geographic divergence in the 
nasopharyngeal microbiome. Hence empirically, due to co-evolution between human 
and microorganism, evolutionary stable strategies will invoke different loci (in host 
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and pathogen) in geographically isolated populations, and the nature of the strategy 
likely will vary with local host population size and dynamics. In particular, large and 
expanding populations, such as the European population, favour higher virulence in 
microorganisms, whereas smaller populations sizes, such as the Inuit, North 
American, Maori, or Australian Aborigine, tend to favour less virulent strains (Real & 
Biek 2007). With the advent of European world exploration in the 15th Century, 
indigenous populations became exposed to virulent respiratory microorganisms co-
evolved with Europeans, to which they had not evolved specific immunity.  
 There is (indirect) evidence in support of this hypothesis. Population genetics 
modeling confirms predicted divergence of host-pathogen co-evolutionary strategy in 
allopatric populations (Best et al 2011). Indeed sampling of flora in sites such as the 
oral cavity (Caufield 2009) or stomach (Linz et al 2007, Yamaoka 2009) confirms 
geographic variations in bacterial genotype (Wirth et al 2005). Similarly, allele 
frequencies in immunomodulatory loci have been found to differ between ethnic 
groups (Van Dyke et al 2009) (although the functional effect of these variations is not 
well understood). Furthermore, population genetics predicts potential catastrophic 
infectious disease from the coalescence of groups that historically have been spatially 
segregated (Best et al 2011). History documents this effect, whereby Old World 
diseases such as smallpox and measles introduced by colonisation of the New World 
were responsible for the decimation of biologically naïve native populations. 
Importantly, accounts from the time suggest that a similar effect occurred even with 
pathogens to which these populations were not entirely naïve.  
 To find evidence of this effect for otitis media is more difficult. Middle ear 
disease is not documented in historical records from the time of European 
colonisation. However, suppurative OM can arrest pneumatisation of the mastoid 
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bone, and archaeological evidence in ancient fossilized skulls of both the native 
American (Gregg & Steele 1982) and the Greenland Inuit (Homoe et al 1996a) does 
suggest an increase in OM subsequent to European colonisation. Genetic variation in 
the nasopharyngeal flora by ethnic groups has not been studied, either in 
contemporary or bioarchaeological remains, but the nasopharynx of Australian 
Aborigine children is known to be colonized by potential otopathogens at an earlier 
age (Leach et al 1994) and in higher numbers (Watson et al 2006), and this is 
predictive of subsequent middle ear suppuration (Smith-Vaughan et al 2006). This 
supports the idea that Aborigine populations are colonised by variants of 
nasopharyngeal commensals with which they have not co-evolved, and to which they 
may not have the genetic repertoire to mount a directed and specific immune 
response. More frequent and more dense nasopharyngeal colonisation by 
otopathogens has also been documented in the Inuit (Homoe et al 1996b).  
 If nasopharyngeal host-pathogen co-evolution is responsible for ethnic 
variations in OM, we would predict variation in susceptibility to other respiratory 
infections. Indeed epidemiological studies show that childhood LRTI is highly 
prevalent in the Inuit (Banerji et al 2001, Banerji et al 2009, Koch et al 2002, Young 
et al 2007), native American (Bockova et al 2002, Holman et al 2004, Lowther et al 
2000, Meissner 2003, Peck et al 2005), Maori (Grant et al 1998, Grimwood et al 
2008, Tukuitonga et al 2000), and Aborigine populations (Carville et al 2007, Dede et 
al 2010, Gracey et al 1992, Moore et al 2007, Read et al 1996, Williams et al 1997). 
An obvious confounder for this association is that many of these indigenous 
populations also suffer lower socio-economic status, which will also increase their 
risk of infectious disease. However, most of these epidemiological studies have 
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controlled for variation in socio-economic status, and found that prevalence remains 
high even after such control. 
 The confluence of populations disparate in their genetics and microbiology 
may not be the only relevant change to occur following European colonization of 
indigenous groups. Prior to European contact many indigenous groups lived in small 
groups and often with a nomadic lifestyle, whereas following colonization many lived 
in larger groups in a fixed abode. Such changes to the structure of indigenous 
societies can also have important effects on host-pathogen dynamics. 
 Future studies to support the hypothesis presented here could look to evaluate 
strain and substrain variation in the nasopharyngeal microbiome in indigenous 
populations compared to non-indigenous populations. However, I recognise that 
results may be compounded by the fact that many indigenous and non-indigenous 
populations are now in regular contact, meaning that they may share a microbiome in 
common. Studies on (rare) human populations that still live in relative isolation may 
be another way to answer this question. 
 
Conclusion 
Otiis media has been prevalent throughout the history of modern humans, and is 
subjective to evolutionary selection pressure. Forces at interplay in the evolution of 
otitis media have been explored here, and include those affecting middle ear function, 
colonization of the nasopharynx by potential pathogens, and host immunity. The 
ecology of human populations is predicted to play a strong role in determining the 
evolutionarily stable state with regards to otitis media, and disruption of this ecology 
by European colonization may explain the contemporary high prevalence of otitis 
media in previously isolated indigenous populations. 
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Table 
Summary of published data documenting increased prevalence of otitis media in the Native American, Inuit, Maori, and Australian 
Aborigine indigenous groups. Note that, for comparison, the prevalence of CSOM in white children in a developed world environment is 
estimated at less than 1% (Bhutta 2014). References for data: a) Curns et al, 2002; b) Singleton et al, 2009; c) Pedersen and Zachau-
Christiansen, 1986; d) Maynard et al, 1972; e) Zonis, 1968; f) Gribben et al, 2012; g) Giles and Asher, 1991; h) Hamilton et al, 1980, i) 
Boswell and Nienhuys, 1995; j) Morris et al 1995; k) Williams et al, 2009; l) Gunasekera et al, 2007; m) Rothstein et al 2007. For the 
Aborigine Australian, also see the review by Jervis-Bardy et al (2014). 
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Figure 1: The middle ear is an air-filled cleft (shaded pink). Anatomically it is divided into 
the Eustachian tube, the tympanic cavity, and the mastoid air cell system. Functionally it is 
partitioned into an immune defence function in the antero-inferior portion, and a trans-
mucosal gas exchange function in the postero-superior portion.  
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Figure 2: Genera found on metagenomic analysis of the nasopharynx microbiome of 18-month old infants. Adapted from Bogaert et al, 
2011. 
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Figure 3: Nasal Associated Lymphatic Tissue (NALT) as a component of the immune system. Artwork adapted from Toronto Notes (Chen & 
Tran 2011). 
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Figure 4. A simplified map of human population migrations prior to onset of European world colonization (c.500 years ago). Annotations are 
focused on populations known to have a high contemporary incidence of OM. Data derived from a number of sources (Gibbard & van 
Kolfschoten 2004, Kayser 2010, McEvoy et al 2010, Mulligan et al 2004, Tamm et al 2007).
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